Surgical Sutures Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Surgical Sutures Market Report is Segmented by Product Type (Absorbable Sutures [Natural and Synthetic] and More), Construction (Monofilament and More), Application (General Surgery and More), Distribution Channel (Offline and More), Coating (Uncoated and Coated), End-User (Hospitals and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Surgical Sutures Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Surgical Sutures Market with other markets in Healthcare Industry

Surgical Sutures Market Analysis by Mordor Intelligence

The surgical sutures market size stands at USD 5.43 billion in 2025 and is on track to reach USD 7.07 billion by 2030, advancing at a 5.42% CAGR. Rising global surgical volumes, the growing footprint of ambulatory surgical centers and rapid uptake of knotless barbed sutures are reinforcing demand across specialties. Product innovation is shifting toward synthetic absorbable materials with embedded antimicrobials, while Healthcare 4.0 initiatives are integrating digital supply-chain tracking to head off shortages and recall risks. Robot-assisted procedures, now commonplace in high-income countries, are pushing manufacturers to tailor constructions that secure tissue under minimal tactile feedback. Asia-Pacific is accelerating fastest, yet North America remains the single-largest revenue pool thanks to sustained reimbursement support for advanced wound-closure devices.

Key Report Takeaways

  • By product type, absorbable sutures held 60.46% of the surgical sutures market size in 2024 and are also the fastest-growing product category, advancing at a 5.67% CAGR through 2030. 
  • By construction, multifilament sutures accounted for 59.38% of the surgical sutures market share in 2024, while barbed sutures are projected to grow the quickest at a 7.23% CAGR to 2030. 
  • By application, general surgery contributed 26.79% of sales in 2024; cardiovascular surgery is set to record the highest growth at a 5.81% CAGR over the forecast period. 
  • By distribution channel, direct tender and GPO purchases represented 44.51% of 2024 revenue, whereas online channels are poised for the fastest expansion at a 6.54% CAGR through 2030. 
  • By coating, uncoated sutures commanded 65.02% share in 2024, yet coated variants are expected to outpace all others with a 6.09% CAGR. 
  • By end-user, hospitals captured 61.82% of demand in 2024, while ambulatory surgical centers are projected to post a 6.15% CAGR, the highest among end-users. 
  • By geography, North America led with 42.53% share in 2024, and Asia-Pacific is forecast to be the fastest-growing region, expanding at a 6.19% CAGR to 2030.

Segment Analysis

By Product Type: Absorbable Sutures Drive Innovation

Absorbable formats generated 60.46% of surgical sutures market size in 2024, advancing at 5.67% CAGR as hospitals seek products that dissolve post-healing and spare patients follow-up removal. The synthetic sub-segment, led by polyglactin and polydioxanone, benefits from uniform absorption profiles[4]Hye-Ree Han, “Antibiotic Action, Drug Delivery, Biodegradability, and Wound Regeneration Characteristics of Surgical Sutures and Cutting-Edge Surgical Suture Manufacturing Technologies,” Journal of Functional Biomaterials, mdpi.com that translate to predictable healing curves. Many of these lines carry antimicrobial triclosan coatings that reduce SSI risk. Non-absorbables remain indispensable in cardiovascular and orthopedic procedures but show slower expansion as sealants encroach on applications once reserved for permanent support. Catgut availability is tightening because of ethical sourcing scrutiny, prompting laboratories to explore albumin-based proteins that break down cleanly without triggering inflammation.

The development pipeline is crowded with electrospun absorbables that integrate antibiotic or growth-factor reservoirs. These fibers deliver a local therapeutic payload while retaining minimum knot-pull strength for up to four weeks, a specification attractive to outpatient centers focused on fast discharge. Though natural silk still finds use in select dentistry cases, its higher bacterial adherence is slowing wider uptake. Premium synthetic lines therefore capture a greater share of the surgical sutures market by positioning on infection reduction, staff convenience and patient comfort.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Construction: Barbed Sutures Transform Surgical Efficiency

Multifilament braids controlled 59.38% of the surgical sutures market size in 2024, thanks to superior pliability and knot security. However, barbed formats lead growth at 7.23% CAGR because their self-gripping texture removes the knotting step, lowering operation time in laparoscopic and robot-assisted fields. Early clinical programs validated barbed sutures in plastic surgery, but expanded clearances now cover gynecology and digestive procedures, boosting unit demand. Investment continues in bidirectional barbs that lock tissue from the mid-point outward, spreading tension evenly and cutting foreign-body load.

Monofilaments persist in vascular grafting where low drag and smooth passage are decisive. New surface-treated monofilaments combine nano-scale texturing with antibacterial ions, ensuring microbial resistance without sacrificing flexibility. Collectively these refinements heighten the surgical sutures market appeal of premium constructions that maximize theater efficiency and postoperative outcomes.

By Application: Cardiovascular Surgery Leads Growth

General surgery accounted for the largest procedure count and 26.79% of the surgical sutures market size in 2024, yet cardiovascular surgery heads the growth charts with 5.81% CAGR. High-pressure hemodynamic environments demand ultra-strong non-absorbables or slowly resorbing barbed sutures that preserve lumen integrity. Product design emphasizes needle geometry capable of penetrating calcified vessel walls without tearing. Orthopedics leans on braided absorbables for tendon re-attachment, while ophthalmology relies on 10-0 or finer monofilaments for micro-incisions. Aesthetic disciplines seek ultrafine clear sutures that minimize scar visibility. Each clinical niche underlines the breadth of engineering requirements underpinning the surgical sutures market.

By Distribution Channel: Online Growth Accelerates

Direct tenders and group purchasing organizations (GPOs) yielded 44.51% of the surgical sutures market share in 2024 by bundling multi-year contracts at volume discounts. Digitalization is reshaping procurement, and online marketplaces are forecast to log 6.54% CAGR as smaller clinics use e-catalogs to bypass intermediaries and source niche gauges on demand. E-commerce also supports just-in-time restocking during supply alerts, protecting case schedules from shipment delays. Offline distributors retain importance in regions where hands-on training accompanies new product launches, particularly for barbed and drug-eluting lines that require revised handling techniques.

Surgical Sutures Market: Market Share by Distribution Channel
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Coating: Coated Sutures Drive Premium Segment

Uncoated versions still held 65.02% of the surgical sutures market size in 2024, given their lower unit cost and broad indication scope. Nevertheless, coated varieties are growing 6.09% CAGR, anchored by robust clinical evidence that antimicrobial barriers lower SSI incidence. Triclosan dominates early adoption, but silver-composite and peptide-based coatings are gaining traction as multiresistant organisms proliferate. Manufacturers must navigate rigorous biocompatibility trials, but successful candidates command price premiums that lift overall surgical sutures market profitability.

By End-User: ASCs Drive Market Expansion

Hospitals consumed 61.82% of the surgical sutures market share in 2024 as complex surgeries remained inpatient. Yet ambulatory surgical centers are the fastest riser, expanding 6.15% because payers favor same-day discharge models that slash facility costs. The typical ASC values sutures that cut closure time and shrink infection risk within short observation windows. Customized ASC packs featuring barbed absorbables and color-coded needles give suppliers an edge in this high-turnover environment. Specialty clinics and emergency departments form a smaller but steady channel, demanding kits that simplify staff training and speed procedural turnover.

Geography Analysis

North America contributed 42.53% of global revenue in 2024 and is forecast to add USD 0.82 billion in incremental value by 2030. Medicare’s USD 6.8 billion outlay on ASC services evidences resilient procedural demand, while FDA vigilance over pediatric shortages is prompting dual-sourcing agreements that stabilize supplies. Home-grown giants such as Johnson & Johnson funneled USD 1.3 billion into surgical-instrument R&D during 2025, cementing the region’s innovation leadership.

Europe advances at 5.28% CAGR on the back of aging demographics and harmonized CE-mark pathways. Sustainability targets are steering purchasing committees toward biodegradable synthetics that minimize environmental burden. Eastern European expansion programs create uptake for mid-tier products, balancing premium innovation seen in Germany and France.

Asia-Pacific records the highest 6.19% CAGR as health-insurance coverage widens and procedure volumes surge in China and India. Local manufacturers are scaling polypropylene and polyglactin lines to cut import reliance, thereby expanding the addressable surgical sutures market size for regional suppliers. Middle East & Africa’s 5.74% CAGR is buoyed by multi-specialty hospital projects, while South America’s 5.65% trajectory reflects improving healthcare access in Brazil and Argentina.

Surgical Sutures Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The competitive arena remains moderately concentrated, dominated by multinational portfolios that stretch from basic nylon to drug-eluting absorbables. Ethicon continues to set the technology pace with STRATAFIX barbed families and triclosan coatings that demonstrate clear SSI reductions. Medtronic registered USD 8.4 billion in Medical Surgical revenue during fiscal 2025, spotlighting vessel-sealing synergies that cross-sell into suture accounts.

R&D budgets prioritize composite materials, robotic-compatible needles and eco-friendly polymers aimed at meeting ESG mandates. Start-ups employing electrospinning are carving niches with customizable fiber diameters and on-board drug loading.

Market entry barriers stay high due to sterility and tensile validation protocols, yet FDA performance-based pathways are shortening timelines for developers that can demonstrate real-world outcome gains. Digital traceability and predictive analytics are emerging as service differentiators, helping operating rooms track lot numbers and expiration dates in real time.

Surgical Sutures Industry Leaders

  1. B. Braun Melsungen AG

  2. Johnson & Johnson Services, Inc.

  3. Medtronic plc

  4. Smith & Nephew plc

  5. Teleflex Incorporated

  6. *Disclaimer: Major Players sorted in no particular order
Surgical Sutures Market Concentration.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: Medtronic disclosed USD 33.5 billion total revenue, with Medical Surgical Portfolio reaching USD 8.4 billion on 0.8% organic growth, buoyed by LigaSure vessel-sealing lines.
  • October 2024: Corza Medical launched Onatec ophthalmic microsurgical sutures at the American Academy of Ophthalmology meeting.
  • September 2024: Johnson & Johnson MedTech unified its brands, including Ethicon, under the J&J MedTech banner to amplify commercial reach.
  • August 2023: Healthium Medtech introduced TRUMAS Polyglactin 910 and Polydioxanone sutures aimed at minimally invasive surgeries.

Table of Contents for Surgical Sutures Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Surging global surgical volumes driven by ageing & chronic-disease burden
    • 4.2.2 Expansion of healthcare facilities in emerging economies is driving high-volume day surgeries
    • 4.2.3 Rise of robot-assisted / image-guided surgery requiring specialized barbed sutures
    • 4.2.4 Rapid material science advances enabling stronger synthetic absorbable sutures
    • 4.2.5 Demand for antimicrobial & drug-eluting sutures amid SSI-reduction mandates
    • 4.2.6 Favorable reimbursement & device-approval pathways in key markets
  • 4.3 Market Restraints
    • 4.3.1 Growing use of staplers, sealants & MIS techniques reducing suture counts
    • 4.3.2 ESG-driven shortages of catgut/silk & specialty polymers
    • 4.3.3 Recalls & stricter quality-system audits raising compliance costs
    • 4.3.4 Needle-stick infection & workplace-safety concerns
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Absorbable Sutures
    • 5.1.1.1 Natural
    • 5.1.1.1.1 Catgut
    • 5.1.1.1.2 Collagen
    • 5.1.1.2 Synthetic
    • 5.1.1.2.1 Vicryl
    • 5.1.1.2.2 Polyglycolic acid (PGA)
    • 5.1.1.2.3 Other Absorbable Synthetic Sutures
    • 5.1.2 Non-absorbable Sutures
    • 5.1.2.1 Nylon
    • 5.1.2.2 Polypropylene
    • 5.1.2.3 Polyester
    • 5.1.2.4 Silk
    • 5.1.2.5 Other Non-absorbable Sutures
  • 5.2 By Construction
    • 5.2.1 Monofilament
    • 5.2.2 Multifilament
    • 5.2.3 Barbed Sutures
  • 5.3 By Application
    • 5.3.1 General Surgery
    • 5.3.2 Cardiovascular Surgery
    • 5.3.3 Orthopedic Surgery
    • 5.3.4 Ophthalmic Surgery
    • 5.3.5 Neurological Surgery
    • 5.3.6 Obstetrics & Gynecology
    • 5.3.7 Dental & Oral Surgery
    • 5.3.8 Plastic & Cosmetic Surgery
    • 5.3.9 Other Applications
  • 5.4 By Distribution Channel
    • 5.4.1 Direct Tender / GPO
    • 5.4.2 Offline
    • 5.4.3 Online
  • 5.5 By Coating
    • 5.5.1 Uncoated
    • 5.5.2 Coated
  • 5.6 By End-User
    • 5.6.1 Hospitals
    • 5.6.2 Ambulatory Surgical Centers
    • 5.6.3 Other End-Users
  • 5.7 By Geography
    • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
    • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
    • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 India
    • 5.7.3.3 Japan
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
    • 5.7.4 Middle East and Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East and Africa
    • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Competitive Benchmarking
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.4.1 Alfresa Holdings Corporation
    • 6.4.2 Assut Medical SA
    • 6.4.3 B. Braun Melsungen AG
    • 6.4.4 Boston Scientific Corp.
    • 6.4.5 CONMED Corp.
    • 6.4.6 DemeTECH Corp.
    • 6.4.7 Dolphin Sutures
    • 6.4.8 Gunze Limited
    • 6.4.9 Healthium Medtech Ltd
    • 6.4.10 Integra LifeSciences Corporation
    • 6.4.11 International Fiber Corporation
    • 6.4.12 Johnson & Johnson Services, Inc.
    • 6.4.13 Kono Seisakusho Co. Ltd.
    • 6.4.14 Lotus Surgicals Pvt Ltd
    • 6.4.15 Mani Inc.
    • 6.4.16 Medtronic plc
    • 6.4.17 Mellon Medical BV
    • 6.4.18 Orion Sutures India Pvt Ltd
    • 6.4.19 Peters Surgical
    • 6.4.20 Shanghai Pudong Jinhuan Medical Products Co., Ltd.
    • 6.4.21 Smith & Nephew plc
    • 6.4.22 Surgical Specialties Corp.
    • 6.4.23 Teleflex Incorporated
    • 6.4.24 Unisur Lifecare Pvt. Ltd.
    • 6.4.25 Weigao Meidcal international Co., Ltd

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Surgical Sutures Market Report Scope

As per the scope of the report, a suture refers to any strand of material used to litigate blood vessels or tissues to close a surgical site. They play a crucial role in the healing process. The surgical sutures market is segmented by product type, application, end user, and geography. By product type, the market is segmented into absorbable sutures and non-absorbable sutures. The absorbable sutures are further segmented into natural sutures and synthetic sutures. The non-absorbable sutures are further segmented into nylon, prolene, and other non-absorbable sutures. By application the market is segmented into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, and other applications. The other application segment is further segmented into cosmetic and plastic surgery and gynaecological surgery. By end user, the market is segmented into hospitals/clinics and ambulatory surgical centers. The report also covers the market size and forecasts for the surgical sutures market in 17 countries across major regions. For each segment, the market sizing and forecasts have been done on the basis of value (USD).

By Product Type Absorbable Sutures Natural Catgut
Collagen
Synthetic Vicryl
Polyglycolic acid (PGA)
Other Absorbable Synthetic Sutures
Non-absorbable Sutures Nylon
Polypropylene
Polyester
Silk
Other Non-absorbable Sutures
By Construction Monofilament
Multifilament
Barbed Sutures
By Application General Surgery
Cardiovascular Surgery
Orthopedic Surgery
Ophthalmic Surgery
Neurological Surgery
Obstetrics & Gynecology
Dental & Oral Surgery
Plastic & Cosmetic Surgery
Other Applications
By Distribution Channel Direct Tender / GPO
Offline
Online
By Coating Uncoated
Coated
By End-User Hospitals
Ambulatory Surgical Centers
Other End-Users
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Absorbable Sutures Natural Catgut
Collagen
Synthetic Vicryl
Polyglycolic acid (PGA)
Other Absorbable Synthetic Sutures
Non-absorbable Sutures Nylon
Polypropylene
Polyester
Silk
Other Non-absorbable Sutures
By Construction
Monofilament
Multifilament
Barbed Sutures
By Application
General Surgery
Cardiovascular Surgery
Orthopedic Surgery
Ophthalmic Surgery
Neurological Surgery
Obstetrics & Gynecology
Dental & Oral Surgery
Plastic & Cosmetic Surgery
Other Applications
By Distribution Channel
Direct Tender / GPO
Offline
Online
By Coating
Uncoated
Coated
By End-User
Hospitals
Ambulatory Surgical Centers
Other End-Users
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

Which suture construction is most favored for robot-assisted procedures?

Barbed sutures are preferred because their self-anchoring design removes knot-tying steps and shortens operative time.

How do antimicrobial coatings influence hospital purchasing?

Facilities increasingly select coated sutures to lower surgical site infection rates and meet value-based reimbursement goals.

Why are ambulatory surgical centers shaping new product designs?

ASCs demand sutures that enable rapid, reliable closure and minimal postoperative complications to support same-day discharge protocols.

What material innovations are improving absorbable suture performance?

Advanced synthetic polymers provide predictable degradation and enhanced elasticity, resulting in secure tissue approximation during healing.

How is regulatory scrutiny affecting manufacturers?

Stringent quality audits and higher recall risks are prompting producers to strengthen supply-chain transparency and compliance systems.

In what way is sustainability influencing suture material choices?

ESG initiatives are driving a shift away from animal-derived fibers toward biodegradable synthetic alternatives with lower environmental impact.

Page last updated on: June 23, 2025

Surgical Sutures Market Report Snapshots